Partial response to carboplatin in an RRx-001 pretreated patient with EGFR-inhibitor-resistance and T790M-negative NSCLC

Few therapeutic options are available for T790M-negative non-small cell lung cancer (NSCLC) after failure of primary epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) and chemotherapy. This report presents the case of a 71-year-old Asian female never smoker with EGFR mutated T7...

Descripción completa

Detalles Bibliográficos
Autores principales: Carter, Corey A., Oronsky, Bryan, Caroen, Scott, Scicinski, Jan, Cabrales, Pedro, Degesys, Aiste, Brzezniak, Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913156/
https://www.ncbi.nlm.nih.gov/pubmed/27330954
http://dx.doi.org/10.1016/j.rmcr.2016.04.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913156/
https://www.ncbi.nlm.nih.gov/pubmed/27330954
http://dx.doi.org/10.1016/j.rmcr.2016.04.007

Ejemplares similares